Lobbying registration dated 2026-03-31
Registrant: Paul Williams
Client: Emergent BioSolutions Canada Inc.
Targeted institutions:
Public Health Agency of Canada (PHAC)
Canadian Centre for Occupational Health and Safety (CCOHS)
Health Canada (HC)
Indigenous Services Canada (ISC)
Finance Canada (FIN)
National Defence (DND)
Innovation, Science and Economic Development Canada (ISED)
Government funding received:
Lobbying activity details:
To advocate for ongoing funding through for Indigenous groups the Emergency Treatment Fund.
To increase access to publicly funded nasal naloxone.
To discuss proposal to leverage medical countermeasure (biodefence) manufacturing in Canada as portion of NATO GDP commitment. Explore partnership and investment opportunities to support the growth of the life sciences sector in Manitoba.